Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 1,300 |
| Receivables | 1,080 |
| Inventories | 760 |
| Other current assets | 60 |
| TOTAL | $3,200 |
| Non-Current Assets | |
| PPE Net | 4,050 |
| Investments And Advances | 680 |
| Other Non-Current Assets | 900 |
| TOTAL | $5,630 |
| Total Assets | $8,850 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 160 |
| Accounts payable and accrued liabilities | 920 |
| Accrued Expenses | 1,010 |
| TOTAL | $2,910 |
| Non-Current Liabilities | |
| Long Term Debt | 1,960 |
| Other Non-Current Liabilities | 6,350 |
| TOTAL | $8,310 |
| Total Liabilities | $11,230 |
| Shareholders' Equity | |
| Common Shares | 40 |
| Retained earnings | -22,590 |
| Other shareholders' equity | 20 |
| TOTAL | $-2,370 |
| Total Liabilities And Equity | $8,860 |